Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Jaguar Health (JAGX) Treasury Shares (2016 - 2025)

Jaguar Health (JAGX) has disclosed Treasury Shares for 11 consecutive years, with $8408.0 as the latest value for Q3 2025.

  • On a quarterly basis, Treasury Shares fell 59.68% to $8408.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $8408.0, a 59.68% decrease, with the full-year FY2024 number at $220.0, down 87.76% from a year prior.
  • Treasury Shares was $8408.0 for Q3 2025 at Jaguar Health, down from $10434.0 in the prior quarter.
  • In the past five years, Treasury Shares ranged from a high of $3.5 million in Q1 2022 to a low of $22.0 in Q4 2022.
  • A 5-year average of $717295.6 and a median of $20852.0 in 2024 define the central range for Treasury Shares.
  • Peak YoY movement for Treasury Shares: surged 6762252.0% in 2022, then plummeted 99.95% in 2025.
  • Jaguar Health's Treasury Shares stood at $6499.0 in 2021, then crashed by 99.66% to $22.0 in 2022, then soared by 8072.73% to $1798.0 in 2023, then plummeted by 87.76% to $220.0 in 2024, then soared by 3721.82% to $8408.0 in 2025.
  • Per Business Quant, the three most recent readings for JAGX's Treasury Shares are $8408.0 (Q3 2025), $10434.0 (Q2 2025), and $1420.0 (Q1 2025).